Shilpen Patel
Executive Medical Director, Oncology, & Global Development Lead AbbVie
Dr. Shilpen Patel is the Global Development Leader at AbbVie managing multiple assets. He has held various positions within the industry where he was instrumental in advancing their oncology pipeline, focusing on targeted therapies for lung cancer and other solid tumors where he has contributed to multiple drug filings.
Dr. Patel is passionate about advancing inclusive research and has led efforts to address social determinants of health, promoting the inclusion of minority groups in clinical studies. His commitment to global health is evident in his work with various nonprofits and as a board member in the equity and global health sectors.
Seminars
Tuesday 24th February 2026
Exploring Clinical Profile & Approval Journey of EMRELIS Against Nonsquamous Non-Small Cell Lung Cancer With High c-Met Protein Overexpression
6:00 pm
- Introducing rationale for targeting c-Met and breaking down Teliso-V design and development, including tandem companion diagnostic development against c-Met
- Diving into Phase II LUMINOSITY safety and efficacy readouts on clinical outcomes in NSCLC patients that lead to FDA accelerated approval
- Highlighting lessons learned from development journey in an indication without an approved ADC therapy, and understanding what this means for other ADC programmes
